マイケル・ネスト（修士）

Michael Nest is a senior Supply Chain leader with more than 25 years of experience spanning all aspects of global investigational and clinical supply operations across small molecule, biologic, and rare disease pharmaceutical organizations. He brings deep expertise across Phase I–IV development, including drug substance (DS), drug product (DP), and finished goods (FG) demand planning, packaging and labeling, IRT/RTSM strategy and implementation, CMO oversight, comparator sourcing, logistics, vendor selection and management, budgeting, and cross-functional stakeholder engagement. Michael also brings extensive experience in IRT/RTSM system design, test script development, computerized system validation, and ongoing IRT/RTSM project management oversight, ensuring compliant, efficient, and scalable clinical supply solutions.

Prior to joining Converge, Michael served as Head of Investigational Supply Chain Operations at Blueprint Medicines, where he established and led the global investigational supply organization and ensured uninterrupted supply for both clinical and commercial programs. He directed end-to-end clinical and commercial supply planning (S&OP/D&OP), including manufacturing coordination, inventory strategy, risk mitigation and contingency planning, and global vendor governance.

Michael previously spent more than a decade at Millennium/Takeda Oncology as Senior Manager of Global Clinical Trial Supply Chain, where he oversaw investigational supply activities from Phase I through registration and post-marketing commitments. During his tenure, he supported two successful product launches and implemented cost-optimization initiatives on sourcing comparator products and reduction in laboratory supply spend while maintaining compliance and operational performance.

Earlier in his career, Michael worked in Analytical Development as a Senior Research Associate, where he supported analytical methods development and played a key role in the build-out and qualification of a new GMP analytical laboratory facility.

Michael holds a Master of Science in Physical Chemistry from Brandeis University and a Bachelor of Science in Chemistry from SUNY Binghamton.

SUNY Binghamton
Bachelor of Science in Chemistry

Brandeis University
Master of Science in Physical Chemistry